Clinical Trials Browser

Phase 1/2 × navitoclax × Tumor-Agnostic × Clear all

NCT02079740 2025-09-30

Trametinib and Navitoclax in Treating Patients With Advanced or Metastatic Solid Tumors

Phase 1/2 Active not recruiting

96 enrolled 30 charts

Neoplasm Metastasis